TABLE 2.

AR profiles of identified enterococcal isolates from WI and SU sampling of RTEFs

Season and identification	No. (%) of isolates
	Total	Resistant to druga:
		CIP	CHL	VAN	ERY	AMP	TET	KAN	STR
WI
E. casseliflavus	27 (41.5)	9 (33.4)	2 (7.4)	0	1 (3.7)	0	2 (7.4)	1 (3.7)	1 (3.7)
E. gallinarum	5 (7.7)	0	0	0	0	0	1	0	0
E. hirae	27 (41.5)	0	2 (7.4)	0	1 (3.7)	0	27 (100)	1 (3.7)	0
E. faecalis	5 (7.7)	0	1 (20)	0	1 (20)	0	3 (60)	0	0
E. faecium	1 (1.5)	0	0	0	0	0	0	0	0
Total	65	9 (13.8)	4 (6.1)	0	3 (4.6)	0	33 (50.8)	2 (3.1)	1 (1.5)
SU
E. casseliflavus	21 (27.7)	0	1 (4.8)	0	3 (14.2)	0	2 (10)	0	1 (4.8)
E. gallinarum	2 (2.6)	0	0	0	0	0	2 (100)	1 (50)	0
E. hirae	4 (5.3)	0	0	0	1 (25)	0	4 (100)	0	0
E. faecalis	17 (22.4)	0	0	0	0	0	0	0	0
E. faecium	28 (36.8)	0	0	0	11 (39.2)	0	4 (14.3)	8 (28.5)	0
E. sulfureus	1 (1.3)	0	0	0	0	0	0	1 (100)	0
E. avium	3 (3.9)	0	0	0	2 (66.7)	0	1 (33.3)	0	0
Total	76	0	1 (1.3)	0	17 (22.3)	0	13 (17.1)	10 (13.2)	1 (1.3)

^aCIP, ciprofloxacin; CHL, chloramphenicol; VAN, vancomycin; ERY, erythromycin; AMP, ampicillin; TET, tetracycline; KAN, kanamycin; STR, streptomycin.